Showing results (321-330 of 517) with videos related to

Sort By:
Pageof 52
British Journal of Cancer|May 17, 2019
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancerMaria Frantzi, Enrique Gomez Gomez, Ana Blanca Pedregosa, et al.
Nutrients|December 31, 2025
Knowledge Gaps, Sleep Disturbances, and Energy Imbalance Among Female Field Hockey PlayersXavier Puchalt-Urbano, Andrea Calderón-García, Jesús R Huertas, et al.
Reproduction (Cambridge, England)|June 24, 2024
Dual role of valosin-containing protein (VCP/p97) in mouse sperm during capacitationMartina Jabloñski, Florenza A La Spina, Liza J Schiavi-Ehrenhaus, et al.
Journal of Endocrinological Investigation|February 13, 2024
Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experienceM Luque-Ramírez, L Nattero-Chávez, C Rodríguez-Rubio Corona, et al.
Acta Physiologica (Oxford, England)|March 11, 2026
Pravastatin Corrects Endothelial Dysfunction in Ex Vivo Uterine Radial Arteries in PreeclampsiaNathan M Luque, Leo Leader, Sandra M Lowe, et al.
International Journal of Molecular Sciences|February 15, 2022
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs ResistanceAntonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, et al.
Reviews in Endocrine & Metabolic Disorders|October 11, 2023
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesityJesús M Pérez-Gómez, Antonio J Montero-Hidalgo, Antonio C Fuentes-Fayos, et al.
Hepatology (Baltimore, Md.)|March 6, 2026
Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through non-canonical SAGA-MYC signalling modulationNatalia Hermán-Sánchez, Maite G Fernández-Barrena, Paloma E Alañón-Martínez, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 4, 2012
Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signalingMario Durán-Prado, Manuel D Gahete, Elena Delgado-Niebla, et al.
Pageof 52